You are here: Welcome to the MPKB » Welcome to the MPKB » Resources for patients » Introduction to the Marshall Protocol
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Next revisionBoth sides next revision
home:patients:protocol_overview [07.03.2017] – [Introduction to the Marshall Protocol] duration determined + by the level of immune dysregulation which has occurred and the unavoidable immune suppressants to which the patient is exposed sallieqhome:patients:protocol_overview [08.19.2018] – [Read more] sallieq
Line 18: Line 18:
 The objective of the MP is to safely activate a [[home:pathogenesis:innate_immunity#antimicrobial_peptides|highly versatile]] defense, the innate immune response. By strengthening the innate immune response, the MP targets the mix of microbes including bacteria, fungi, and viruses that play a role in chronic disease. As pathogens and infected human cells die, they generate inflammation (sometimes called a "cytokine storm") and release endotoxins into the body, resulting in a temporary increase in patients' original symptoms. This is known as immunopathology (generally abbreviated to IP). The objective of the MP is to safely activate a [[home:pathogenesis:innate_immunity#antimicrobial_peptides|highly versatile]] defense, the innate immune response. By strengthening the innate immune response, the MP targets the mix of microbes including bacteria, fungi, and viruses that play a role in chronic disease. As pathogens and infected human cells die, they generate inflammation (sometimes called a "cytokine storm") and release endotoxins into the body, resulting in a temporary increase in patients' original symptoms. This is known as immunopathology (generally abbreviated to IP).
  
-Treatment on the MP requires a [[home:patients:mp_duration|number of years]] to complete, but the exact duration is determined by the level of immune dysregulation which has occurred and the unavoidable immune suppressants to which the patient is exposed while fighting their way back to healthy immune function. +Treatment on the MP requires a [[home:patients:mp_duration|number of years]] to complete, but the exact duration is determined by degree of illness and any unavoidable immune suppressants to which the patient is exposed.
  
 The MP is to be administered only by a [[home:starting:physician|licensed physician]] competent in use of the Marshall Protocol. The available evidence for the treatment's effectiveness is [[home:physicians:concerns#concerns_about_lack_of_clinical_evidence|described here]]. The MP is to be administered only by a [[home:starting:physician|licensed physician]] competent in use of the Marshall Protocol. The available evidence for the treatment's effectiveness is [[home:physicians:concerns#concerns_about_lack_of_clinical_evidence|described here]].
Line 24: Line 24:
 ===== Medications used ===== ===== Medications used =====
  
 +
 +The document [[home:mp|Marshall Protocol]] is a one-article summary of key issues related to the Marshall Protocol, especially those relevant to physicians.  Many of the topics covered here are reviewed in greater depth throughout the Knowledge Base. 
 +
 +Without active participation of patients on MarshallProtocol.com site, Autoimmunity Research Foundation does not support or license the public use of this therapy.
  
  
  
-{{section>:home:mp#Summary_of_Marshall_Protocol_medications_and_dosages&noheader}} 
  
  
Line 85: Line 88:
   * [[home:starting|Starting the Marshall Protocol]]   * [[home:starting|Starting the Marshall Protocol]]
   * [[home:mp:stages|Stages of illness and recovery]]   * [[home:mp:stages|Stages of illness and recovery]]
 +  * [[home:special:effects_of_emf:about_rf]]
  
- 
- 
-{{tag>Simple_Explanations}} 
  
  
Line 96: Line 97:
  
  
 +{{tag>Simple_Explanations}}
  
   * Legacy content   * Legacy content
home/patients/protocol_overview.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.